ILLUMINATE


This project received funding from the European Union / Grant Agreement Number pending.

Euro-BioImaging is part of ILLUMINATE (Increasing lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership collaborative research program funded by the Innovative Health Initiative (IHI, https://www.ihi.europa.eu/apply-funding/ihi-call-5 ) that combines research and pre-clinical development. ILLUMINATE will provide the first clinical translation of MeMRI, with application to castrate resistant metastatic prostate cancer. This breakthrough could lead to improved diagnosis and treatment, offering new tools for medical teams and new hope for patients.

Coordinated by Prof. Dennis Klomp from UMC Utrecht (Dutch High Field MR Node), ILLUMINATE is a collaborative effort that gathers 15 public and private partners from five countries (Netherlands, Finland, Germany, Italy and Sweden): six industrial partners (imaging instrumentation and pharma), three Nodes (a second facility from the Dutch High Field MR Node, three facilities from the MMMI Node and one facility from the NMI Node), two research organisations and an expertise centre for public-private partnerships.

In ILLUMINATE, Euro-BioImaging contributes to Work Package 5, "Patient and Public Engagement & Education for Healthcare Professionals and Scientists", and Work Package 6 "Programme Management and Communications", leading the task related to educational activities, and will enable the imaging modalities developed in the project to be accessible through the Euro-BioImaging web portal.

The programme's total budget is 21M€ (11.6M€ from the European Commission, 6.1M€ from industrial partners, and 3.6M€ from contributing partners), of which 4,6M€ are earmarked for the Nodes.

Read the press release here.
More info about ILLUMINATE ihi-illuminate.org

Funded by the EU

ILLUMINATE News

Illuminate_hero

October 21, 2024

ILLUMINATE brings together private-public partners to advance novel theranostics-based cancer treatments

Euro-BioImaging is thrilled to be part of ILLUMINATE (Increasing Lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership…